Elovl4tm1Wked
Targeted Allele Detail
|
Symbol: |
Elovl4tm1Wked |
Name: |
ELOVL fatty acid elongase 4; targeted mutation 1, Wojciech Kedzierski |
MGI ID: |
MGI:3711216 |
Synonyms: |
Elov14mut |
Gene: |
Elovl4 Location: Chr9:83660745-83688330 bp, - strand Genetic Position: Chr9, 45.6 cM
|
Alliance: |
Elovl4tm1Wked page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:121481
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129/SvEv
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutation: |
|
Nucleotide substitutions
|
|
|
Mutation details: A targeting vector was designed to insert a floxed neo and DNA construct containing a pathogenic 5-bp deletion ((797-801_AACTT) and two point mutations in exon 6. This construct resulted in a truncated protein which contains the same aberrant 8-amino acid C-terminus encoded by the human pathogenic allele. The floxed neo was subsequently removed via cre mediated recombination.
(J:121481)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Elovl4 Mutation: |
36 strains or lines available
|
|
Original: |
J:121481 McMahon A, et al., Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol Vis. 2007;13:258-72 |
All: |
5 reference(s) |
|